In today’s pharma and MedTech environment, success no longer depends only on what to say, but also on how engagement is orchestrated across stakeholders and rep/non-rep channels. Pharma companies often have extensive CRM data through Veeva or similar systems, showing who was contacted, through which channel, and how often. However, these data rarely explain why some interactions drive action while others do not. Primary market research helps connect the dots by exploring how stakeholders perceive different touchpoints, how engagement journeys unfold in real life, and which sequences truly influence decisions. This includes journey mapping, touchpoint optimization, and segmentation that goes beyond attitudes to incorporate channel preferences, digital behaviours, and receptivity to rep, medical, and digital interactions.